Published by ChinaMNC · Yuanqu
China’s Health Sector Priorities for 2026–2030: What Foreign Founders Need to Know
A national health conference outlines China’s health-sector goals for the next five years, with implications for foreign founders in healthcare, medtech, and related industries.
China’s Health Sector Priorities for 2026–2030: What Foreign Founders Need to Know
On October 12–13, 2026, China held its National Health Conference in Beijing. President Xi Jinping delivered a major speech outlining the direction for the health sector during the 15th Five-Year Plan period (2026–2030), a critical window for achieving the goal of building a “Healthy China” by 2035. For foreign founders considering registering a company or operating in China’s healthcare market, these priorities signal where opportunities and regulatory focus are likely to grow.
Key Takeaways from the Conference
1. Health as a Strategic Priority
Xi emphasized that people’s health is a key marker of national prosperity. Since the 18th Party Congress, the government has placed health security in a strategic position, establishing a new-era health policy and launching the Healthy China initiative. The conference noted that China has built the world’s largest systems for medical services, traditional medicine, disease prevention and control, and medical insurance. For foreign founders, this indicates a mature but still expanding healthcare ecosystem with diverse needs.
2. Vision of a Balanced and Efficient Health System
The “Healthy China” to be built is described as balanced, inclusive, high-quality, and efficient. It should possess strong capabilities in health management, disease prevention and control, medical services, medical insurance support, pharmaceutical innovation, and talent cultivation. This vision aims to meet growing public health demands and steadily improve major health indicators.
3. Health in All Policies
Xi stressed that health must be integrated into all policies. When formulating plans, designing policies, evaluating projects, and constructing infrastructure, the impact on public health should be considered as a priority. This “health in all policies” approach may affect sectors beyond healthcare, including construction, environment, and food.
4. Prevention First
Prevention is highlighted as the most cost-effective health strategy. The government will focus on foundational and source-level health work, guiding society to adopt healthy lifestyles, improving food safety oversight, and strengthening the disease prevention and control system to prevent large-scale epidemics.
5. Improving Medical Services
A key task is to comprehensively raise the level of medical services. This includes implementing a project to strengthen primary healthcare, optimizing the layout of medical institutions, promoting tiered diagnosis and treatment, enhancing chronic disease management, and advancing the inheritance and innovation of traditional Chinese medicine with integrated Chinese-Western medicine. The conference also calls for basic research and original innovation in health, promotion of technology transfer, and expansion of the health industry.
6. Reform as a Driving Force
Reform is seen as a powerful engine for health development. The main direction is the coordinated development and governance of medical services, medical insurance, and pharmaceuticals. Public hospitals will deepen reform with a focus on public welfare, and a multi-tiered medical insurance system will be built. Policies on centralized drug procurement, insurance payment, and fund usage will be optimized. The drug supply guarantee mechanism and the national essential medicines system will be improved, with strengthened quality and safety supervision.
7. Talent and Workforce
Building a strong workforce is essential. The conference calls for selecting capable leaders for health authorities and medical institutions, creating a sufficient, well-structured, and high-quality team of medical personnel, and fostering a social atmosphere that respects medical workers.
8. Global Health Cooperation
Xi noted that health for all is a shared global vision. China will actively promote a global community of health for all, deepen health cooperation under the Belt and Road Initiative, and innovate foreign health aid. Telling the “Healthy China” story aims to build international consensus.
Implications for Foreign Founders
These priorities suggest several areas where foreign founders might find opportunities or need to align with policy:
- Primary healthcare and tiered diagnosis: The push to strengthen primary care and tiered diagnosis could open doors for companies offering telemedicine, clinic management software, or training services.
- Chronic disease management and prevention: With an emphasis on prevention and chronic disease management, digital health tools, wearable devices, and health management platforms may see growing demand.
- Traditional Chinese Medicine (TCM): The conference highlights TCM innovation and integration with Western medicine. Foreign companies in natural products, wellness, or integrative medicine might explore partnerships.
- Pharmaceutical innovation and R&D: The call for basic research and original innovation, along with technology transfer, could benefit foreign biotech and medtech firms establishing R&D centers in China.
- Health industry: The goal to “expand and strengthen the health industry” signals continued support for private and foreign investment in healthcare services, eldercare, and health products.
- Medical insurance and drug procurement: Reforms in insurance and centralized procurement may affect pricing and market access strategies. Foreign founders should stay informed about provincial procurement platforms and insurance catalog dynamics.
Practical Considerations for Registration and Operation
While the conference sets broad direction, foreign founders must still navigate China’s specific regulatory landscape. Healthcare is a highly regulated sector. Depending on your business scope—such as medical devices, pharmaceuticals, health software, or clinics—you may need to obtain special licenses from the National Medical Products Administration (NMPA) or health commissions. Company registration itself follows the general Foreign Investment Law, but negative lists may restrict certain activities. It is advisable to consult local authorities or professional advisors to confirm whether your planned activities fall under encouraged, restricted, or prohibited categories.
Additionally, the emphasis on “health in all policies” suggests that environmental, safety, and quality standards will be strictly enforced. Building compliance into your operations from the start is essential.
Conclusion
China’s health-sector priorities for 2026–2030 emphasize prevention, primary care, innovation, and global cooperation. For foreign founders, these areas may offer pathways to contribute and grow. However, success requires careful attention to local regulations and a long-term commitment to quality and compliance.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
Call to Action: Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.